4893 items matching your search terms.

Effect of pravastatin on cardiovascular events in older patients, women, and diabetics. The prava-3 pooling project

Sacks, F.M. Hawkins, C.M. Tonkin, A.M. Keech, A. Cobbe, S.M. Packard, C. Furberg, C.

Lipids, Atherosclerosis and Reduction in Cardiovascular Events: Lessons from the LIPID Trial and other major cholesterol trials

Simes, J.

Cholesterol, cholesterol lowering treatment and the risk of stroke

Simes, J.

Impact of cholesterol lowering treatment on cardiovascular events in patients with coronary heart disease

Simes, J.

International differences in treatment and clinical outcomes in international cardiovascular trials: methodological issues

Simes, J.

Strategies for new trials in Australasian Gastro-Intestinal Trials Group

Simes, J.

The role of clinical trials in evidence-based medicine. ii) Surrogate outcomes and treatment mechanisms in clinical trials. iii) Pitfalls and approaches to subgroup analysis iv) Translating trial evidence into clinical practice: present and future directions

Simes, J.

Pitfalls and approaches to subgroup analysis

Simes, J.

MSAC: a strategy to acquire evidence for health service technologies when the evidence is lacking. Health services research and technology assessment forum on research strategies and priorities

Simes, J.

Pravastatin reduces mortality in patients with a broad range of lipid levels or without prior coronary heart disease: The Prospective Pravastatin Pooling Project [poster].

Simes, J.; Braunwald, E.; Shepherd, J.; Craven, T.; Davis, B.; Fuberg, C.; on behalf of the project investigators

Reduction in coronary events with pravastatin and proportion of treatment benefit explained by on-study lipid levels in the LIPID Study

Simes, J.; Marschner, I.; Hunt, D.; Colquhoun, D.; Glasziou, P.; Hague, W.; MacMahon, S.; Keech, A.C.; Tonkin, A.

Lipids and atherosclerosis. Prevention of death and cardiovascular events with lipid therapies. Results from LIPID and other recent large scale trials

Simes, R.J.

Prevention of death and cardiovascular events with cholesterol treatment using pravastatin in patients with coronary heart disease (CHD) and average cholesterol levels

Simes, R.J.

Surrogate outcomes and treatment mechanisms in clinical trials

Simes, R.J.

Impact of cholesterol treatments on reduction of cardiovascular events in recent large scale trials

Simes, R.J.